275 related articles for article (PubMed ID: 36264074)
1.
Emmanuel N; Li H; Chen J; Zhang Y
Oncotarget; 2022 Oct; 13():1136-1139. PubMed ID: 36264074
[TBL] [Abstract][Full Text] [Related]
2. A targetable CoQ-FSP1 axis drives ferroptosis- and radiation-resistance in KEAP1 inactive lung cancers.
Koppula P; Lei G; Zhang Y; Yan Y; Mao C; Kondiparthi L; Shi J; Liu X; Horbath A; Das M; Li W; Poyurovsky MV; Olszewski K; Gan B
Nat Commun; 2022 Apr; 13(1):2206. PubMed ID: 35459868
[TBL] [Abstract][Full Text] [Related]
3. FSP1 confers ferroptosis resistance in KEAP1 mutant non-small cell lung carcinoma in NRF2-dependent and -independent manner.
Kim JW; Kim MJ; Han TH; Lee JY; Kim S; Kim H; Oh KJ; Kim WK; Han BS; Bae KH; Ban HS; Bae SH; Lee SC; Lee H; Lee EW
Cell Death Dis; 2023 Aug; 14(8):567. PubMed ID: 37633973
[TBL] [Abstract][Full Text] [Related]
4. Nrf2 inhibition reverses resistance to GPX4 inhibitor-induced ferroptosis in head and neck cancer.
Shin D; Kim EH; Lee J; Roh JL
Free Radic Biol Med; 2018 Dec; 129():454-462. PubMed ID: 30339884
[TBL] [Abstract][Full Text] [Related]
5. Nrf2 inhibition reverses the resistance of cisplatin-resistant head and neck cancer cells to artesunate-induced ferroptosis.
Roh JL; Kim EH; Jang H; Shin D
Redox Biol; 2017 Apr; 11():254-262. PubMed ID: 28012440
[TBL] [Abstract][Full Text] [Related]
6. SIRT6 silencing overcomes resistance to sorafenib by promoting ferroptosis in gastric cancer.
Cai S; Fu S; Zhang W; Yuan X; Cheng Y; Fang J
Biochem Biophys Res Commun; 2021 Nov; 577():158-164. PubMed ID: 34530350
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathological, microenvironmental and genetic determinants of molecular subtypes in KEAP1/NRF2-mutant lung cancer.
Cai MC; Chen M; Ma P; Wu J; Lu H; Zhang S; Liu J; Zhao X; Zhuang G; Yu Z; Fu Y
Int J Cancer; 2019 Feb; 144(4):788-801. PubMed ID: 30411339
[TBL] [Abstract][Full Text] [Related]
8. Molecular mechanisms for the regulation of Nrf2-mediated cell proliferation in non-small-cell lung cancers.
Yamadori T; Ishii Y; Homma S; Morishima Y; Kurishima K; Itoh K; Yamamoto M; Minami Y; Noguchi M; Hizawa N
Oncogene; 2012 Nov; 31(45):4768-77. PubMed ID: 22249257
[TBL] [Abstract][Full Text] [Related]
9. DPP9 Stabilizes NRF2 to Suppress Ferroptosis and Induce Sorafenib Resistance in Clear Cell Renal Cell Carcinoma.
Chang K; Chen Y; Zhang X; Zhang W; Xu N; Zeng B; Wang Y; Feng T; Dai B; Xu F; Ye D; Wang C
Cancer Res; 2023 Dec; 83(23):3940-3955. PubMed ID: 37713596
[TBL] [Abstract][Full Text] [Related]
10. Cisplatin synergizes with PRLX93936 to induce ferroptosis in non-small cell lung cancer cells.
Liang Z; Zhao W; Li X; Wang L; Meng L; Yu R
Biochem Biophys Res Commun; 2021 Sep; 569():79-85. PubMed ID: 34237431
[TBL] [Abstract][Full Text] [Related]
11. Role of KEAP1/NRF2 and TP53 Mutations in Lung Squamous Cell Carcinoma Development and Radiation Resistance.
Jeong Y; Hoang NT; Lovejoy A; Stehr H; Newman AM; Gentles AJ; Kong W; Truong D; Martin S; Chaudhuri A; Heiser D; Zhou L; Say C; Carter JN; Hiniker SM; Loo BW; West RB; Beachy P; Alizadeh AA; Diehn M
Cancer Discov; 2017 Jan; 7(1):86-101. PubMed ID: 27663899
[TBL] [Abstract][Full Text] [Related]
12. miR-125b-5p in adipose derived stem cells exosome alleviates pulmonary microvascular endothelial cells ferroptosis via Keap1/Nrf2/GPX4 in sepsis lung injury.
Shen K; Wang X; Wang Y; Jia Y; Zhang Y; Wang K; Luo L; Cai W; Li J; Li S; Du Y; Zhang L; Zhang H; Chen Y; Xu C; Zhang J; Wang R; Yang X; Wang Y; Hu D
Redox Biol; 2023 Jun; 62():102655. PubMed ID: 36913799
[TBL] [Abstract][Full Text] [Related]
13. Activation of Atg7-dependent autophagy by a novel inhibitor of the Keap1-Nrf2 protein-protein interaction from
Sun Y; He L; Wang W; Xie Z; Zhang X; Wang P; Wang L; Yan C; Liu Z; Zhao J; Cui Z; Wang Y; Tang L; Zhang Z
Food Funct; 2022 Jul; 13(14):7885-7900. PubMed ID: 35776077
[TBL] [Abstract][Full Text] [Related]
14. Meningioma achieves malignancy and erastin-induced ferroptosis resistance through FOXM1-AURKA-NRF2 axis.
Ye Y; Xu L; Zhang L; Zhao P; Cai W; Fu G; Wang T; Tao Z; Shi W; Gu W; Hu J; Yuan G; Wei Y; Xu K; Bao Z; Chao H; Liu N; Zhao L; Tu Y; Ji J
Redox Biol; 2024 Jun; 72():103137. PubMed ID: 38642502
[TBL] [Abstract][Full Text] [Related]
15. KEAP1-Mutant NSCLC: The Catastrophic Failure of a Cell-Protecting Hub.
Scalera S; Mazzotta M; Cortile C; Krasniqi E; De Maria R; Cappuzzo F; Ciliberto G; Maugeri-Saccà M
J Thorac Oncol; 2022 Jun; 17(6):751-757. PubMed ID: 35351670
[TBL] [Abstract][Full Text] [Related]
16. The discovery and characterization of K-563, a novel inhibitor of the Keap1/Nrf2 pathway produced by Streptomyces sp.
Hori R; Yamaguchi K; Sato H; Watanabe M; Tsutsumi K; Iwamoto S; Abe M; Onodera H; Nakamura S; Nakai R
Cancer Med; 2019 Mar; 8(3):1157-1168. PubMed ID: 30735010
[TBL] [Abstract][Full Text] [Related]
17. LKB1 and KEAP1/NRF2 Pathways Cooperatively Promote Metabolic Reprogramming with Enhanced Glutamine Dependence in
Galan-Cobo A; Sitthideatphaiboon P; Qu X; Poteete A; Pisegna MA; Tong P; Chen PH; Boroughs LK; Rodriguez MLM; Zhang W; Parlati F; Wang J; Gandhi V; Skoulidis F; DeBerardinis RJ; Minna JD; Heymach JV
Cancer Res; 2019 Jul; 79(13):3251-3267. PubMed ID: 31040157
[TBL] [Abstract][Full Text] [Related]
18. Keap1-Nrf2 Pathway Regulates ALDH and Contributes to Radioresistance in Breast Cancer Stem Cells.
Kamble D; Mahajan M; Dhat R; Sitasawad S
Cells; 2021 Jan; 10(1):. PubMed ID: 33419140
[TBL] [Abstract][Full Text] [Related]
19. [Nrf2 and Keap1 Abnormalities in 104 Lung Adenocarcinoma Cases and Association with Clinicopathologic Features].
Xiao Y; Zhu X; Gu Y; Chen S; Liang L; Cao B
Zhongguo Fei Ai Za Zhi; 2018 Mar; 21(3):241-250. PubMed ID: 29587953
[TBL] [Abstract][Full Text] [Related]
20. Induction of ferroptosis by ATF3 elevation alleviates cisplatin resistance in gastric cancer by restraining Nrf2/Keap1/xCT signaling.
Fu D; Wang C; Yu L; Yu R
Cell Mol Biol Lett; 2021 Jun; 26(1):26. PubMed ID: 34098867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]